From 1999-2010, 10,700 women age 15-44 participated in the interview portion of NHANES, among whom 209 reported a diabetes diagnosis. Among 10,491 women who reported no diabetes diagnosis, 6,881 (65.6%, based on survey sample weights) and 4,352 (41.5%) had A1C and FPG laboratory values available for analysis, respectively. Among those, 30 had A1C values suggesting undiagnosed diabetes (A1C ≥6.5), compared to 28 based on FPG values (≥126 mg/dl) (Table) . Although there was not sufficient sample size to produce reliable estimates of the percentage of non-pregnant US women of reproductive age with undiagnosed diabetes based on these data, the weighted survey estimates suggest it may be approximately 0.5%. The current population of US women age 15-44 is 61,606,000 [11] . Our results suggest approximately 300,000 women of reproductive age nationwide may have undiagnosed diabetes. An additional 284 (4.0%) and 438 (11.2%) women from our sample were at risk of diabetes based on A1C values (5.7-<6.5%) and FPG values (100-<126 mg/dl), respectively, suggesting approximately 2.5 to 7 million more women of reproductive age may be at risk for diabetes (Table) . Given that 49% of pregnancies in the U.S. are unplanned, our findings suggest many pregnancies might be affected by unrecognized diabetes [12] .
Among pregnant women 15-44 years in NHANES 1999-2010 (n=1,173), none had undiagnosed diabetes based on our criteria. However, we show here a noteworthy number of women who may become pregnant have elevated glucose values; this has serious implications for women's health during pregnancy and the postpartum period, as well as the health of the developing fetus. Identifying and treating women with elevated glucose in the preconception period might ultimately help reduce adverse birth outcomes for thousands of women nationwide.
The prevalence of undiagnosed diabetes in the general US population varies significantly by age and race/ethnicity [1] . Even with the power of the NHANES data, the population we examined was small and therefore the estimates were somewhat unstable. This issue inhibited examination of differences by women's demographic characteristics-including race/ethnicity-as well as the scope of conclusions we can draw from our results. Because of these drawbacks, explanation of our analysis was best suited to a brief report format. However, these results point to the importance of additional future examination of undiagnosed and pre-diabetes among women of reproductive age.
